Fulcrum Therapeutics (($FULC)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Fulcrum The......

Fulcrum Therapeutics ( ($FULC) ) has released its Q3 earnings. Here is a breakdown of the information Fulcrum Therapeutics presented to its investo......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quoin Pharmaceuticals (QNRX – Research Report) and F......

Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Fulcrum Therapeutics today and set a price target of $15.00. The company’s shares op......